![Jesper Gromada](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jesper Gromada
Private Equity Investor bei
Third Rock Ventures LLC
Profil
Jesper Gromada is currently a Venture Partner at Third Rock Ventures LLC since 2022.
Former positions include Associate Director at Eli Lilly & Co. from 2000 to 2006, VP - Muscle and Metabolism Therapeutic Areas at Regeneron Pharmaceuticals, Inc. from 2012 to 2018, Chief Scientific Officer at Exonics Therapeutics, Inc. from 2018 to 2019, Site Head-Vertex Genetic Therapies at Vertex Pharmaceuticals, Inc. from 2019 to 2020, and Chief Scientific Officer at Laronde, Inc. from 2020 to 2022.
Education includes a doctorate from the University of Copenhagen conferred in 1995.
Aktive Positionen von Jesper Gromada
| Unternehmen | Position | Beginn |
|---|---|---|
Third Rock Ventures LLC
 Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures invests in companies located in the United States. The firm focuses on the healthcare. It participates in early stage capital requirements. The firm also acts as lead investor. | Private Equity Investor | 01.09.2022 |
Ehemalige bekannte Positionen von Jesper Gromada
| Unternehmen | Position | Ende |
|---|---|---|
Laronde Inc.
 Laronde Inc. Miscellaneous Commercial ServicesCommercial Services Develops an eRNA therapeutic platform that capable diverse proteins inside body | Corporate Officer/Principal | 01.09.2022 |
| VERTEX PHARMACEUTICALS INCORPORATED | Corporate Officer/Principal | 01.10.2020 |
Exonics Therapeutics, Inc.
 Exonics Therapeutics, Inc. BiotechnologyHealth Technology Develops therapies for neuromuscular diseases | Corporate Officer/Principal | 01.07.2019 |
| REGENERON PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01.10.2018 |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | 01.01.2006 |
Ausbildung von Jesper Gromada
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
71
Beziehungen ersten Grades
7
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
Eli Lilly & Co.
 Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
Regeneron Pharmaceuticals, Inc.
 Regeneron Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops, manufactures and commercializes medicines for diseases | Health Technology |
Vertex Pharmaceuticals, Inc.
 Vertex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops drugs for the treatment of cystic fibrosis | Health Technology |
University of Copenhagen
 University of Copenhagen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Third Rock Ventures LLC
Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures invests in companies located in the United States. The firm focuses on the healthcare. It participates in early stage capital requirements. The firm also acts as lead investor. | Finance |
Exonics Therapeutics, Inc.
Exonics Therapeutics, Inc. BiotechnologyHealth Technology Develops therapies for neuromuscular diseases | Health Technology |
Laronde Inc.
Laronde Inc. Miscellaneous Commercial ServicesCommercial Services Develops an eRNA therapeutic platform that capable diverse proteins inside body | Commercial Services |
Wählen Sie MarketScreener 
